Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
Sat - Sun: Closed
+ (123) 1800-453-1546
info@example.com

Related Posts

Welcome to MedicalPress a Premium Medical Theme

Products

HCV

Biorex Diagnostics have developed rapid test devices and strips for the qualitative detection of HCV antibodies in whole blood, serum or plasma.

Hepatitis C Virus is a small, enveloped, positive-sense, single-stranded RNA virus. HCV is now known to be the major cause of parenterally transmitted non-A, non-B hepatitis. Antibody to HCV is found in over 80% of patients with well-documented non-A, non-B hepatitis. Conventional methods fail to isolate the virus in cell culture or visualize it by electron microscope. Cloning the viral genome has made it possible to develop serologic assays that use recombinant antigens. Compared to the first generation HCV EIAs using single recombinant antigen, multiple antigens using recombinant protein and/or synthetic peptides have been added in new serologic tests to avoid nonspecific cross-reactivity and to increase the sensitivity of the HCV antibody tests.

Add to Quote

Description

Product Name CAT.No Size
HCV Device (Serum/Plasma/Whole Blood) HCVC0020 20T
HCV Device (Serum/Plasma/Whole Blood) HCVC0040 40T
HCV Device (Serum/Plasma/Whole Blood) HCVC0050 50T
HCV Device (Serum/Plasma/Whole Blood) HCVC0100 100T

 

 

Product Description

The Biorex Diagnostics HCV Rapid Test Devices are rapid immunochromatographic assays for the qualitative detection of Hepatitis C Virus (HCV) antibodies in whole blood, serum, or plasma. They provide fast and reliable screening for early detection, clinical management, and blood safety monitoring.

Key Features
• Rapid detection – qualitative results within minutes
• High sensitivity and specificity – reliable identification of HCV antibodies
• Versatile sample compatibility – works with whole blood, serum, or plasma
• Easy-to-use – minimal training required, suitable for point-of-care or laboratory settings
• Ready-to-use format – simple procedure, clear visual interpretation, reduced errors

Benefits
Use of the HCV Rapid Test Devices enables early detection of HCV infection, supports blood donor screening, and assists in monitoring treatment response. Its rapid workflow, high analytical performance, and user-friendly design enhance clinical decision-making, improve patient management, and support public health initiatives for HCV prevention and control.

Additional information

Storage

2-8°C